General Range

Conifyllin-FX

Price on request/100 · MOQ 100 boxes

Conifyllin-FX Tablets by Coniak Lifesciences contain Montelukast, Fexofenadine and Acebrophylline (SR), a combination of medicines intended for selected respiratory conditions involving allergic symptoms, airway inflammation and bronchial obstruction.

Montelukast is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, substances involved in airway inflammation and allergic reactions. It may help control certain asthma symptoms and allergic rhinitis when clinically appropriate.

Fexofenadine is a second-generation antihistamine that blocks histamine H1 receptors, helping relieve allergy-related symptoms such as sneezing, runny nose, itching and watery eyes.

Acebrophylline is a xanthine-derived respiratory medicine with bronchodilator and mucus-regulating properties. Its sustained-release (SR) formulation is designed to release the active ingredient gradually over time.

Conifyllin-FX Tablets may be prescribed for selected patients experiencing respiratory symptoms associated with allergic conditions and chronic airway obstruction when the combination is considered medically appropriate.

The medicine should be taken strictly according to a registered medical practitioner's prescription. Dosage and treatment duration depend on the patient's respiratory condition, medical history and response to treatment.

CategoryGeneral Range

Min. Order100 boxes

Supplied byConiak Lifesciences

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Montelukast, Fexofenadine & Acebrophylline (SR) Tablets
Packaging Type: Tablets
Packaging Size: 10 × 10
Dosage Form: Tablet
Treatment: May be prescribed for selected patients requiring maintenance treatment for asthma.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Coniak LifesciencesPanchkula, Haryana

View Full Profile

Coniak Lifesciences is a WHO-GMP and ISO 9001:2015 certified pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana, India.

Key Company Details

• Established: 2014
• Headquarters: Plot No. 208, Industrial Area, Phase-1, Panchkula, Haryana, 134113
• Certifications: WHO-GMP and ISO certified
• Phone Number: +91-9570599567
• Official Website: Coniak Lifesciences

Core Operations & Offerings

• Product Formulations: Manufactures and supplies allopathic, herbal, Ayurvedic, and nutraceutical medicines.
• Dosage Forms: Tablets, capsules, softgels, syrups, dry syrups, injections, ointments, protein powders, pediatric drops, and dental solutions.
• Featured Brands: Conipraz LSR, Itrarap 100, Conisure P, Cincred 25, and Coniphage-N.
• Business Model: Offers pan-India PCD pharma franchise opportunities with monopoly rights alongside third-party and contract manufacturing services.
• Investment Range: Franchise partnerships typically require an initial investment ranging from ₹50,000 to ₹1.5 lakh depending on the product range.
Would you like details on their product catalog, monopoly territory availability, or franchise terms?